UA84141C2 - Применение ингибитора пктжк для лечения или профилактики запора - Google Patents
Применение ингибитора пктжк для лечения или профилактики запораInfo
- Publication number
- UA84141C2 UA84141C2 UAA200508758A UA2005008758A UA84141C2 UA 84141 C2 UA84141 C2 UA 84141C2 UA A200508758 A UAA200508758 A UA A200508758A UA 2005008758 A UA2005008758 A UA 2005008758A UA 84141 C2 UA84141 C2 UA 84141C2
- Authority
- UA
- Ukraine
- Prior art keywords
- iват
- constipation
- prophylaxis
- inhibitor
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Изобретение относится к применению ингибитора подвздошно-кишечного транспорта желчных кислот (ПКТЖК) или его фармацевтически приемлемой соли, сольвата, сольвата такой соли или пролекарств; фармацевтической композиции названных соединений в сочетании с фармацевтически приемлемым разбавителем или носителем для получения препарата, применяемого для лечения и/или профилактики запора.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0307918.3A GB0307918D0 (en) | 2003-04-05 | 2003-04-05 | Therapeutic use |
PCT/GB2004/001396 WO2004089350A1 (en) | 2003-04-05 | 2004-04-01 | Use of an ibat inhibitor for the treatment of prophylaxis of constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
UA84141C2 true UA84141C2 (ru) | 2008-09-25 |
Family
ID=9956272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200508758A UA84141C2 (ru) | 2003-04-05 | 2004-04-01 | Применение ингибитора пктжк для лечения или профилактики запора |
Country Status (33)
Country | Link |
---|---|
US (1) | US7514421B2 (ru) |
EP (2) | EP1894564B1 (ru) |
JP (2) | JP4870552B2 (ru) |
KR (1) | KR101321577B1 (ru) |
CN (1) | CN100366241C (ru) |
AR (1) | AR043985A1 (ru) |
AT (2) | ATE387194T1 (ru) |
AU (1) | AU2004228731B2 (ru) |
BR (1) | BRPI0408858A (ru) |
CA (1) | CA2520109C (ru) |
CO (1) | CO5640076A2 (ru) |
CY (2) | CY1107424T1 (ru) |
DE (1) | DE602004012079T2 (ru) |
DK (2) | DK1610770T3 (ru) |
ES (2) | ES2299832T3 (ru) |
GB (1) | GB0307918D0 (ru) |
HK (1) | HK1085666A1 (ru) |
IL (1) | IL170913A (ru) |
IS (1) | IS8113A (ru) |
MX (1) | MXPA05010706A (ru) |
MY (1) | MY137757A (ru) |
NO (1) | NO335140B1 (ru) |
NZ (1) | NZ542835A (ru) |
PL (2) | PL1894564T3 (ru) |
PT (2) | PT1894564E (ru) |
RU (2) | RU2342928C2 (ru) |
SA (1) | SA04250066B1 (ru) |
SI (2) | SI1894564T1 (ru) |
TW (1) | TWI338577B (ru) |
UA (1) | UA84141C2 (ru) |
UY (1) | UY28258A1 (ru) |
WO (1) | WO2004089350A1 (ru) |
ZA (1) | ZA200507996B (ru) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
PL216023B1 (pl) | 2001-09-08 | 2014-02-28 | Astrazeneca Ab | Pochodna benzotiadiazepiny, kompozycja farmaceutyczna zawierajaca pochodna benzotiadiazepiny oraz zastosowania pochodnej benzotiadiazepiny |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
GB0304194D0 (en) * | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
CA2679314A1 (en) | 2007-03-08 | 2008-09-12 | Albireo Ab | 2-substituted-3-phenylpropionic acid derivatives and their use in the treatment of inflammatory conditions |
EP2367554A4 (en) * | 2008-11-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | BILIARY ACID RECYCLING INHIBITORS FOR THE TREATMENT OF OBESITY AND DIABETES |
EP4137137A1 (en) | 2010-05-26 | 2023-02-22 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
CN103260625B (zh) | 2010-11-08 | 2016-01-06 | 阿尔比里奥公司 | 用于治疗肝脏疾病的ibat抑制剂 |
CN104023718B (zh) | 2011-10-28 | 2017-04-05 | 鲁美纳医药公司 | 用于治疗高胆血症和胆汁淤积性肝病的胆汁酸再循环抑制剂 |
JP6217938B2 (ja) | 2011-10-28 | 2017-10-25 | ルメナ ファーマシューティカルズ エルエルシー | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 |
BR112015023646A2 (pt) | 2013-03-15 | 2017-07-18 | Lumena Pharmaceuticals Inc | inibidores de ácidos biliares de reciclagem para tratamento de colangite esclerosante primária e doença inflamatória do intestino |
JP2016514678A (ja) | 2013-03-15 | 2016-05-23 | ルメナ ファーマシューティカルズ エルエルシー | バレット食道と胃食道逆流性疾患を処置するための胆汁酸再利用阻害剤 |
JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
KR101420315B1 (ko) * | 2014-03-19 | 2014-07-17 | 남봉길 | 약학적 액제 조성물 |
CN106659726A (zh) * | 2014-06-25 | 2017-05-10 | Ea制药株式会社 | 固体制剂及其着色防止或着色减少方法 |
CN106573033A (zh) * | 2014-06-25 | 2017-04-19 | Ea制药株式会社 | 固体制剂及其稳定化方法 |
EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
CA2995798A1 (en) | 2015-08-17 | 2017-02-23 | Nipul Ghanshyambhai PATEL | Liquid formulations containing picosulfate and magnesium citrate |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
DK3643718T3 (da) | 2017-06-20 | 2023-11-06 | Takeda Pharmaceuticals Co | Heterocyklisk forbindelse og anvendelse deraf som positiv allosterisk modulator af den kolinerge muskarin m1-receptor |
JP2020530448A (ja) | 2017-08-09 | 2020-10-22 | アルビレオ・アクチボラグ | コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用 |
BR112020017353A2 (pt) | 2018-03-09 | 2020-12-15 | Elobix Ab | Processos para a preparação de um composto e de uma modificação de cristal iv de elobixibat. |
US10428109B1 (en) | 2018-03-09 | 2019-10-01 | Elobix Ab | Process for the preparation of 1,5-benzothiazepine compounds |
WO2019234077A1 (en) | 2018-06-05 | 2019-12-12 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
TWI823954B (zh) | 2018-06-20 | 2023-12-01 | 瑞典商艾爾比瑞歐公司 | 奧德維希百(odevixibat)之結晶修飾物 |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
AU2020223022A1 (en) | 2019-02-12 | 2021-09-02 | Mirum Pharmaceuticals, Inc. | Methods for increasing growth in pediatric subjects having cholestatic liver disease |
CN114761080B (zh) | 2019-12-04 | 2024-07-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
EP4069359B1 (en) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
CA3158195A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
CN114761018A (zh) | 2019-12-04 | 2022-07-15 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
CN116157389A (zh) | 2020-08-03 | 2023-05-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
CA3198216A1 (en) | 2020-12-04 | 2022-06-09 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
WO2022166680A1 (zh) * | 2021-06-25 | 2022-08-11 | 苏州科睿思制药有限公司 | 奥德昔巴特的晶型及其制备方法和用途 |
WO2023203248A1 (en) | 2022-04-22 | 2023-10-26 | Albireo Ab | Subcutaneous administration of an asbt inhibitor |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO170760C (no) | 1985-01-10 | 1992-12-02 | Tanabe Seiyaku Co | Analogifremgangsmaate for fremstilling av terapeutisk aktive nafthalenderivater |
JPS6310746A (ja) | 1986-07-01 | 1988-01-18 | Tanabe Seiyaku Co Ltd | ナフタレン誘導体 |
US4900757A (en) | 1988-12-08 | 1990-02-13 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane |
DE3930696A1 (de) | 1989-09-14 | 1991-03-28 | Hoechst Ag | Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel |
NZ240846A (en) | 1990-12-06 | 1994-04-27 | Hoechst Ag | Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions |
ATE175954T1 (de) | 1991-10-17 | 1999-02-15 | Shionogi & Co | Verfahren zum herstellen von lignin-analoga und ausgangsprodukte dafür |
FI108451B (fi) | 1991-12-20 | 2002-01-31 | Hoechst Ag | Menetelmõ polymeeristen ja oligomeeristen sappihappojohdannaisten valmistamiseksi |
JPH05186357A (ja) * | 1991-12-31 | 1993-07-27 | Shigeo Ochi | 飲食物消化分解産物吸収抑制手段 |
GB9201180D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
GB9203347D0 (en) | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
ES2111092T3 (es) | 1992-06-12 | 1998-03-01 | Hoechst Ag | Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos. |
IL108633A (en) | 1993-02-15 | 1998-07-15 | Wellcome Found | History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them |
IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
WO1994024087A1 (en) | 1993-04-16 | 1994-10-27 | Shionogi & Co., Ltd. | Process for producing lignan compound |
TW289021B (ru) | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
EP0624593A3 (de) | 1993-05-08 | 1995-06-07 | Hoechst Ag | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel. |
TW289020B (ru) | 1993-05-08 | 1996-10-21 | Hoechst Sktiengesellschaft | |
ZA956647B (en) | 1994-08-10 | 1997-02-10 | Wellcome Found | Hypolipidaemic compounds. |
ATE199718T1 (de) | 1994-09-13 | 2001-03-15 | Monsanto Co | Benzothepines mit wirkung als inhibitoren des gallensäuretransports und der taurocholate- aufnahme |
US5994391A (en) | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
GB9423172D0 (en) | 1994-11-17 | 1995-01-04 | Wellcom Foundation The Limited | Hypolipidemic benzothiazepines |
DE69734100D1 (de) | 1996-03-11 | 2005-10-06 | G D Searle Llc St Louis | Benzothiepinen mit wirkung als inhibitoren des ileumgallensäuretransports und der taurocholate-aufnahme |
WO1998007749A1 (en) | 1996-08-23 | 1998-02-26 | Human Genome Sciences, Inc. | Novel human growth factors |
JPH1072371A (ja) | 1996-08-28 | 1998-03-17 | Sankyo Co Ltd | 回腸型胆汁酸トランスポーター阻害剤 |
GB9704208D0 (en) | 1997-02-28 | 1997-04-16 | Glaxo Group Ltd | Chemical compounds |
NZ337830A (en) | 1997-03-11 | 2001-07-27 | G | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
EP0864582B1 (en) | 1997-03-14 | 2003-06-04 | Aventis Pharma Deutschland GmbH | Hypolipidemic 1,4-benzothiazepine-1,-dioxides |
PT869121E (pt) | 1997-04-04 | 2004-10-29 | Aventis Pharma Gmbh | Derivados de propanolamina hipolipidemicos |
DE19845402B4 (de) | 1998-10-02 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
WO1998056757A1 (fr) | 1997-06-11 | 1998-12-17 | Sankyo Company, Limited | Derives de benzylamine |
AUPO763197A0 (en) | 1997-06-30 | 1997-07-24 | Sigma Pharmaceuticals Pty Ltd | Health supplement |
WO1999032478A1 (en) | 1997-12-19 | 1999-07-01 | G.D. Searle & Co. | Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
GB9800428D0 (en) | 1998-01-10 | 1998-03-04 | Glaxo Group Ltd | Chemical compounds |
DE19825804C2 (de) | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19845406C2 (de) | 1998-10-02 | 2001-10-18 | Aventis Pharma Gmbh | Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
DE19845403B4 (de) | 1998-10-02 | 2005-02-10 | Aventis Pharma Deutschland Gmbh | Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
DE19845405C2 (de) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
AU1684400A (en) | 1998-12-11 | 2000-07-03 | Sankyo Company Limited | Substituted benzylamines |
JP2002533414A (ja) | 1998-12-23 | 2002-10-08 | ジー.ディー.サール エルエルシー | 心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ |
BR9916567A (pt) | 1998-12-23 | 2001-12-11 | Searle Llc | Combinações de inibidores do transporte ácido dabile ileal e derivados do ácido nicotìnico paraindicações cardiovasculares |
US6458851B1 (en) | 1998-12-23 | 2002-10-01 | G. D. Searle, Llc | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
IL143944A0 (en) | 1998-12-23 | 2002-04-21 | Searle Llc | Combinations for cardiovascular indications |
PT1140189E (pt) | 1998-12-23 | 2003-09-30 | Searle Llc | Combinacoes de inibidores do transporte do acido biliar ileal e de derivados do acido fibrico para indicacoes cardiovasculares |
KR20020000139A (ko) | 1999-02-12 | 2002-01-04 | 추후제출 | 회장 담즙산 수송 및 타우로콜산염 흡수의 억제제로서의활성을 보유하는 신규한 1,2-벤조티아제핀 |
DE19916108C1 (de) | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
SE9901387D0 (sv) | 1999-04-19 | 1999-04-19 | Astra Ab | New pharmaceutical foromaulations |
US6287609B1 (en) * | 1999-06-09 | 2001-09-11 | Wisconsin Alumni Research Foundation | Unfermented gel fraction from psyllium seed husks |
CZ290178B6 (cs) | 1999-07-22 | 2002-06-12 | Sankyo Company Limited | Deriváty cyklobutenu |
WO2001034570A1 (fr) | 1999-11-08 | 2001-05-17 | Sankyo Company, Limited | Derives heterocycliques azotes |
JP2003523336A (ja) | 2000-02-18 | 2003-08-05 | メルク エンド カムパニー インコーポレーテッド | 糖尿病及び脂質障害のためのアリールオキシ酢酸 |
SE0000772D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
US6794544B2 (en) | 2000-03-10 | 2004-09-21 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
WO2001068096A2 (en) | 2000-03-10 | 2001-09-20 | Pharmacia Corporation | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
US20020183307A1 (en) | 2000-07-26 | 2002-12-05 | Tremont Samuel J. | Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake |
SE0003766D0 (sv) | 2000-10-18 | 2000-10-18 | Astrazeneca Ab | Novel formulation |
EG26979A (en) * | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
WO2002053548A1 (en) | 2000-12-27 | 2002-07-11 | Banyu Pharmaceutical Co.,Ltd. | Benzothiazepine derivatives |
US6506921B1 (en) * | 2001-06-29 | 2003-01-14 | Virginia Tech Intellectual Properties, Inc. | Amine compounds and curable compositions derived therefrom |
GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
PL216023B1 (pl) * | 2001-09-08 | 2014-02-28 | Astrazeneca Ab | Pochodna benzotiadiazepiny, kompozycja farmaceutyczna zawierajaca pochodna benzotiadiazepiny oraz zastosowania pochodnej benzotiadiazepiny |
GB0201850D0 (en) * | 2002-01-26 | 2002-03-13 | Astrazeneca Ab | Therapeutic treatment |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
GB0216321D0 (en) | 2002-07-13 | 2002-08-21 | Astrazeneca Ab | Therapeutic treatment |
GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
GB0307918D0 (en) * | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
-
2003
- 2003-04-05 GB GBGB0307918.3A patent/GB0307918D0/en not_active Ceased
-
2004
- 2004-04-01 BR BRPI0408858-1A patent/BRPI0408858A/pt not_active Application Discontinuation
- 2004-04-01 AU AU2004228731A patent/AU2004228731B2/en not_active Ceased
- 2004-04-01 US US10/551,999 patent/US7514421B2/en not_active Expired - Lifetime
- 2004-04-01 PL PL07023058T patent/PL1894564T3/pl unknown
- 2004-04-01 SI SI200431710T patent/SI1894564T1/sl unknown
- 2004-04-01 AT AT04725081T patent/ATE387194T1/de active
- 2004-04-01 KR KR1020057018959A patent/KR101321577B1/ko active IP Right Grant
- 2004-04-01 CN CNB200480009415XA patent/CN100366241C/zh not_active Expired - Lifetime
- 2004-04-01 UA UAA200508758A patent/UA84141C2/ru unknown
- 2004-04-01 NZ NZ542835A patent/NZ542835A/en unknown
- 2004-04-01 WO PCT/GB2004/001396 patent/WO2004089350A1/en active IP Right Grant
- 2004-04-01 CA CA2520109A patent/CA2520109C/en not_active Expired - Lifetime
- 2004-04-01 ES ES04725081T patent/ES2299832T3/es not_active Expired - Lifetime
- 2004-04-01 JP JP2006506065A patent/JP4870552B2/ja not_active Expired - Lifetime
- 2004-04-01 ES ES07023058T patent/ES2368350T3/es not_active Expired - Lifetime
- 2004-04-01 DK DK04725081T patent/DK1610770T3/da active
- 2004-04-01 PT PT07023058T patent/PT1894564E/pt unknown
- 2004-04-01 DK DK07023058.6T patent/DK1894564T3/da active
- 2004-04-01 AT AT07023058T patent/ATE513550T1/de active
- 2004-04-01 PL PL04725081T patent/PL1610770T3/pl unknown
- 2004-04-01 SI SI200430662T patent/SI1610770T1/sl unknown
- 2004-04-01 MX MXPA05010706A patent/MXPA05010706A/es active IP Right Grant
- 2004-04-01 EP EP07023058A patent/EP1894564B1/en not_active Expired - Lifetime
- 2004-04-01 RU RU2005128792/15A patent/RU2342928C2/ru active
- 2004-04-01 EP EP04725081A patent/EP1610770B1/en not_active Expired - Lifetime
- 2004-04-01 PT PT04725081T patent/PT1610770E/pt unknown
- 2004-04-01 DE DE602004012079T patent/DE602004012079T2/de not_active Expired - Lifetime
- 2004-04-02 MY MYPI20041236A patent/MY137757A/en unknown
- 2004-04-05 UY UY28258A patent/UY28258A1/es not_active Application Discontinuation
- 2004-04-05 SA SA04250066A patent/SA04250066B1/ar unknown
- 2004-04-05 TW TW093109383A patent/TWI338577B/zh not_active IP Right Cessation
- 2004-04-06 AR ARP040101159A patent/AR043985A1/es not_active Application Discontinuation
-
2005
- 2005-09-15 IL IL170913A patent/IL170913A/en unknown
- 2005-09-21 NO NO20054369A patent/NO335140B1/no unknown
- 2005-10-03 ZA ZA200507996A patent/ZA200507996B/xx unknown
- 2005-10-25 CO CO05108676A patent/CO5640076A2/es not_active Application Discontinuation
- 2005-11-01 IS IS8113A patent/IS8113A/is unknown
-
2006
- 2006-05-16 HK HK06105682A patent/HK1085666A1/xx not_active IP Right Cessation
-
2008
- 2008-04-24 CY CY20081100461T patent/CY1107424T1/el unknown
- 2008-07-17 RU RU2008129204/15A patent/RU2482850C2/ru active
-
2011
- 2011-06-07 JP JP2011127175A patent/JP5421326B2/ja not_active Expired - Lifetime
- 2011-09-07 CY CY20111100862T patent/CY1111995T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA84141C2 (ru) | Применение ингибитора пктжк для лечения или профилактики запора | |
BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
IL152916A0 (en) | Heteroaryl-phenyl heterobicyclic factor xa inhibitors | |
EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
DE60112974D1 (en) | Carbolinderivate | |
SG151254A1 (en) | Substituted morpholine and thiomorpholine derivatives | |
GB0101577D0 (en) | Compounds | |
MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
TW200612919A (en) | Lonidamine analogues and their use in male contraception and cancer treatment | |
MY135233A (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
WO2004050030A3 (en) | Anti-sickling agents | |
DE60216233D1 (en) | Carbolinderivate | |
MXPA05006505A (es) | Composiciones vaginales de sertaconazol. | |
TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
DE60205899D1 (en) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
TW200508199A (en) | Novel compound | |
MXPA02012054A (es) | Compuestos de dicetopiracina tetraciclica como inhibidores de la fosfodiesterasa v. | |
AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
PL369772A1 (en) | Compounds that inhibit factor xa activity | |
YU20902A (sh) | Primena karbinola supstituisanih sa 2-imidazolilom za izradu medikamenta za lečenje ili profilaksu oboljenja izazvanih ishemičkim stanjima |